The Present and Future Use of β-Blockers N. M. Kaplan Section 1A: Hypertension 14 December 2012 Pages: 1 - 4
State-of-the-Art Review: β-Blockade and the Treatment of Hypertension J. I. S. Robertson Section 1A: Hypertension 14 December 2012 Pages: 5 - 11
The Problem of Compliance with Antihypertensive Regimens David L. SackettR. Brian HaynesD. Wayne Taylor Section 1A: Hypertension 14 December 2012 Pages: 12 - 18
Ambulatory Blood Pressure and its Variability During Randomised Double-blind Administration of Atenolol, Metoprolol, Pindolol and Long Acting Propranolol in Subjects with Mild to Moderate Hypertension J. S. FlorasM. O. HassanP. Sleight Section 1A: Hypertension 14 December 2012 Pages: 19 - 25
Dose and Duration of Reponse to β-Blockers in the Treatment of Hypertension J. C. PetrieT. A. JeffersJ. Webster Section 1A: Hypertension 14 December 2012 Pages: 26 - 29
Comparison of Antihypertensive Efficacy of Atenolol, Oxprenolol and Pindolol at Rest and during Exercise E. AmbrosioniF. V. CostaB. Magnani Section 1A: Hypertension 14 December 2012 Pages: 30 - 36
A Comparative Study Between 100mg Atenolol and 20mg Pindolol Slow-Release in Essential Hypertension P. GremingerH. VetterW. Vetter Section 1A: Hypertension 14 December 2012 Pages: 37 - 41
Atenolol Dose-Finding Studies T. IshizakiY. Oyama Section 1B: Hypertension 14 December 2012 Pages: 42 - 49
β-Blockers and Calcium Antagonists F. R. BühlerU. L. HulthénP. Bolli Section 1B: Hypertension 14 December 2012 Pages: 50 - 57
β-Blockers and Renin A. ZanchettiG. LeonettiC. Sala Section 1B: Hypertension 14 December 2012 Pages: 58 - 63
Activation of Prejunctional β-Adrenoceptors by Adrenaline Acting as a Co-transmitter M. J. RandH. MajewskiL.-H. Tung Section 1B: Hypertension 14 December 2012 Pages: 64 - 68
Hypertensive Patients Treated with Atenolol I. Maistrello Short Communication 14 December 2012 Pages: 69 - 70
Atenolol Once Daily in Essential Hypertension C. L. AlicandriE. Agabiti-RoseiG. Muiesan Short Communication 14 December 2012 Pages: 70 - 71
Atenolol in Orally Treated Diabetic Patients L. HausmannK. M. Goebel Short Communication 14 December 2012 Pages: 71 - 73
Italian League Against Hypertension, and Italian Society of Non-Hospital Cardiologists Atenolol Multicentre Study C. Fernandez Short Communication 14 December 2012 Pages: 73 - 74
9 Years’ Experience with Atenolol in the Treatment of Hypertension N. C. Henningsen Short Communication 14 December 2012 Pages: 74 - 75
Indonesian Multicentre Trial in Hypertension T. Darmadji Short Communication 14 December 2012 Pages: 75 - 76
Antihypertensive Effect, at Rest and During Isometric Exercise, of Long Term Treatment with Atenolol L. CoreaM. BentivoglioM. Provvidenza Short Communication 14 December 2012 Pages: 76 - 77
Blood Pressure Response during Isometric and Dynamic Exercise after Long Term Treatment of Essential Hypertension M. MiddekeA. BurkhartH. Holzgreve Short Communication 14 December 2012 Pages: 77 - 78
The Effect of Long Term Therapy for Essential Hypertension with Atenolol and Chlorthalidone on Carbohydrate Tolerance M. Luque OteroC. Fernandez PinillaA. Fernandez-Cruz Short Communication 14 December 2012 Pages: 78 - 80
Effect of Atenolol and Metoprolol on Exercise and Post-Exercise Pulse and Blood Pressure, 24 Hours after Administration A. K. ScottJ. W. RigbyH. G. Lovell Short Communication 14 December 2012 Pages: 80 - 81
A Comparison of Atenolol and Metoprolol Once Daily on Blood Pressure during Rest and Exercise B. E. KarlbergJ.-H. AttenhögK. P. Öhman Short Communication 14 December 2012 Pages: 82 - 83
A Comparison of Antihypertensive Treatment Atenolol Plus Bendrofluazide vs a Combination Tablet, ‘Tenoretic’ D. McAreaveyM. P. Robertson Short Communication 14 December 2012 Pages: 83 - 83
Single Dose Oral Atenolol for Urgent Blood Pressure Reduction L. T. BannanD. G. Beevers Short Communication 14 December 2012 Pages: 84 - 84
Atenolol and Left Ventricular Hypertrophy M. M. Ibrahim Short Communication 14 December 2012 Pages: 85 - 86
Atenolol in the Treatment of Elderly Hypertensive Patients J. D. Summa Short Communication 14 December 2012 Pages: 86 - 87
Multicentre Trial of Treatment of Hypertension in the Elderly in Primary Care J. R. Coope Short Communication 14 December 2012 Pages: 87 - 88
A Combination of Chlorthalidone (12.5mg) and Atenolol (50mg) in the Elderly K. SiamopoulosR. WilkinsonK. Boddy Short Communication 14 December 2012 Pages: 88 - 90
Blood Pressure in Children and its Relevance to Adult Hypertension The Brompton Study M. de SwietP. M. FayersE. A. Shinebourne Short Communication 14 December 2012 Pages: 90 - 91
State-of-the-Art: Comparative Pharmacology of the β-Adrenoceptor Blocking Drugs David G. Shand Section 2A: Pharmacodynamics, Pharmacokinetics and Drug Interactions 14 December 2012 Pages: 92 - 99
Haemodynamic Effects of β-Blockers Jay N. Cohn Section 2A: Pharmacodynamics, Pharmacokinetics and Drug Interactions 14 December 2012 Pages: 100 - 102
β-Adrenoceptor Blocking Drugs and Renal Blood Flow with Special Reference to the Elderly K. O’MalleyW. G. O’CallaghanE. O’Brien Section 2A: Pharmacodynamics, Pharmacokinetics and Drug Interactions 14 December 2012 Pages: 103 - 107
β-Blockers and Renal Function D. J. WarrenD. G. WallerJ. McAinsh Section 2A: Pharmacodynamics, Pharmacokinetics and Drug Interactions 14 December 2012 Pages: 108 - 112
Effect of Liver Function on β-Blocker Kinetics Eero A. SotaniemiR. Olavi PelkonenMarkku Anttila Section 2A: Pharmacodynamics, Pharmacokinetics and Drug Interactions 14 December 2012 Pages: 113 - 120
Inhibition of Drug Metabolism by β-Adrenoceptor Antagonists N. D. S. BaxM. S. LennardH. F. Woods Section 2B: Pharmacodynamics, Pharmacokinetics and Drug Interactions 14 December 2012 Pages: 121 - 126
Influence of β-Receptor Antagonists on Pharmacokinetics of Cimetidine W. KirchH. SpahnE. Mutschler Section 2B: Pharmacodynamics, Pharmacokinetics and Drug Interactions 14 December 2012 Pages: 127 - 130
Stable Oral Availability of Atenolol Coadministered with Hydralazine A. J. McLeanDoris WilhelmB. G. Heinzow Section 2B: Pharmacodynamics, Pharmacokinetics and Drug Interactions 14 December 2012 Pages: 131 - 135
Effect of Oxprenolol on the Pharmacokinetics and Pharmacodynamics of Hydralazine Gabrielle M. HawksworthA. M. DartJ. C. Petrie Section 2B: Pharmacodynamics, Pharmacokinetics and Drug Interactions 14 December 2012 Pages: 136 - 140
Effect of β-Blockade on the Pressor Response to Coffee plus Smoking in Patients with Mild Hypertension Stephen FreestoneLawrence E. Ramsay Section 2B: Pharmacodynamics, Pharmacokinetics and Drug Interactions 14 December 2012 Pages: 141 - 145
Renal Impairment in Hypertension Not Improved by Nadolol when Compared with Atenolol Jane MuellerM. J. ByrneL. H. Opie Short Communication 14 December 2012 Pages: 146 - 146
Atenolol and Liver Function D. LebrecB. FlouvatC. Dupont Short Communication 14 December 2012 Pages: 147 - 147
Impaired Metabolism of Metoprolol in Poor Hydroxylators of Debrisoquine M. S. LennardJ. H. SilasH. F. Woods Short Communication 14 December 2012 Pages: 147 - 148
Effects of Short and Long Term β-Blockade on Changes in Blood Pressure Caused by Cigarette Smoking in Normotensive and Hypertensive Subjects C. CuspidiP. L. AliprandiL. Sampieri Short Communication 14 December 2012 Pages: 148 - 149
Cardiovascular Response to Cigarette Smoking during Adrenergic Block in Essential Hypertension R. FogariA. PariniG. Finardi Short Communication 14 December 2012 Pages: 149 - 150
Alcohol-induced Hypertension D. G. BeeversL. I. BannanJ. F. Potter Short Communication 14 December 2012 Pages: 150 - 152
Interaction Between Alcohol and Metoprolol or Atenolol in Social Drinking W. KirchH. SpahnE. Mutschler Short Communication 14 December 2012 Pages: 152 - 152
β-Blockade for Angina and Arrhythmias Stephen Scheidt Section 3: Angina and Arrhythmias 14 December 2012 Pages: 153 - 159
Atenolol in the Treatment of Angina Once Daily Cardioselective β-Blockade for Angina Pectoris J. B. Schwartz Section 3: Angina and Arrhythmias 14 December 2012 Pages: 160 - 165
Cardioselectivity and Partial Agonist Activity in the Antianginal Efficacy of the β-Adrenoceptor Antagonists B. MagnaniB. MantovaniE. Ambrosioni Section 3: Angina and Arrhythmias 14 December 2012 Pages: 166 - 171
Atenolol in Unstable Angina J. P. GodenirM. AmorA. Bertrand Section 3: Angina and Arrhythmias 14 December 2012 Pages: 172 - 176